The $50 billion elephant in the room is whether there will be enforcement by the FDA against compounders alleging violations of the FDCA prohibition on compounding products that are essentially a copy of FDA-approved products now that the branded GLP-1 products are no longer in shortage
This is the foundational principle of pharmacology, stated by Paracelsus 500 years ago: the dose makes the poison, and by extension, the dose makes the medicine
Amid this epidemic, a transformative class of medications GLP-1 receptor agonists (GLP- 1RAs) has revolutionized weight loss and chronic disease management
reported that semaglutide accessed the brainstem, hypothalamus, and the dorsal half of the septal area, largely via small circumventricular organs, but it was not shown to cross the BBB [27]
Providers must hold a California medical license
Food Service Manager Frequently Asked Questions Youll complete a health review, baseline measurements, and a simple plan for cadence, meals, and movement